研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2024 年 · SiM
Statistics in Medicine,2024 年发表的 297 篇,新的在前。点标题看作者和摘要。回到 2024 年
- Sensitivity Analysis for Effects of Multiple Exposures in the Presence of Unmeasured Confounding: Non‐Gaussian and Time‐to‐Event Outcomes · SiM · 2024-12-30 · 在第 1 页
- Generalized Estimating Equations for Survival Data With Dependent Censoring · SiM · 2024-12-30 · 在第 1 页
- Efficient Risk Assessment of Time‐to‐Event Targets With Adaptive Information Transfer · SiM · 2024-12-30 · 在第 1 页
- Bayesian Decision Curve Analysis With Bayesdca · SiM · 2024-12-30 · 在第 1 页
- Analysis of Longitudinal Lupus Data Using Multivariate t‐Linear Models · SiM · 2024-12-19 · 在第 1 页
- Nonparametric Estimation for Propensity Scores With Misclassified Treatments · SiM · 2024-12-18 · 在第 1 页
- Asymptotic Properties of Matthews Correlation Coefficient · SiM · 2024-12-16 · 在第 1 页
- On GEE for Mean‐Variance‐Correlation Models: Variance Estimation and Model Selection · SiM · 2024-12-12 · 在第 1 页
- A Simple Information Criterion for Variable Selection in High‐Dimensional Regression · SiM · 2024-12-12 · 在第 1 页
- Linear Mixed Modeling of Federated Data When Only the Mean, Covariance, and Sample Size Are Available · SiM · 2024-12-11 · 在第 2 页
- Smooth Hazards With Multiple Time Scales · SiM · 2024-12-09 · 在第 2 页
- Joint Modelling of Longitudinal Measurements and Time‐to‐Event Outcomes With a Cure Fraction Using Functional Principal Component Analysis · SiM · 2024-12-05 · 在第 2 页
- Double Sampling for Informatively Missing Data in Electronic Health Record‐Based Comparative Effectiveness Research · SiM · 2024-12-05 · 在第 2 页
- A Nonparametric Regression Calibration for the Accelerated Failure Time Model With Measurement Error · SiM · 2024-12-05 · 在第 2 页
- Dynamic Treatment Regimes on Dyadic Networks · SiM · 2024-11-28 · 在第 3 页
- Bayesian Nonparametric Model for Heterogeneous Treatment Effects With Zero‐Inflated Data · SiM · 2024-11-28 · 在第 3 页
- Quantifying Overdiagnosis for Multicancer Detection Tests: A Novel Method · SiM · 2024-11-26 · 在第 3 页
- Unlocking Cognitive Analysis Potential in Alzheimer's Disease Clinical Trials: Investigating Hierarchical Linear Models for Analyzing Novel Measurement Burst Design Data · SiM · 2024-11-25 · 在第 3 页
- The Win Ratio Approach in Bayesian Monitoring for Two‐Arm Phase II Clinical Trial Designs With Multiple Time‐To‐Event Endpoints · SiM · 2024-11-25 · 在第 3 页
- Response‐Adaptive Randomization Procedure in Clinical Trials with Surrogate Endpoints · SiM · 2024-11-25 · 在第 3 页
- Survival causal rule ensemble method considering the main effect for estimating heterogeneous treatment effects · SiM · 2024-11-22 · 在第 3 页
- Skewness‐Corrected Confidence Intervals for Predictive Values in Enrichment Studies · SiM · 2024-11-20 · 在第 4 页
- Regression Trees With Fused Leaves · SiM · 2024-11-20 · 在第 4 页
- Q‐Learning in Dynamic Treatment Regimes With Misclassified Binary Outcome · SiM · 2024-11-20 · 在第 4 页
- Statistical Inference for Counting Processes Under Shape Heterogeneity · SiM · 2024-11-19 · 在第 4 页
- Reinforced Borrowing Framework: Leveraging Auxiliary Data for Individualized Inference · SiM · 2024-11-18 · 在第 4 页
- Powerful Test of Heterogeneity in Two‐Sample Summary‐Data Mendelian Randomization · SiM · 2024-11-18 · 在第 4 页
- Instrumental Variable Model Average With Applications in Nonlinear Causal Inference · SiM · 2024-11-18 · 在第 4 页
- Improving Survey Inference Using Administrative Records Without Releasing Individual‐Level Continuous Data · SiM · 2024-11-18 · 在第 4 页
- Statistical Inference for Box–Cox based Receiver Operating Characteristic Curves · SiM · 2024-11-17 · 在第 4 页
- A Partially Randomized Patient Preference, Sequential, Multiple‐Assignment, Randomized Trial Design Analyzed via Weighted and Replicated Frequentist and Bayesian Methods · SiM · 2024-11-17 · 在第 4 页
- Sieve Maximum Likelihood Estimation of Partially Linear Transformation Models With Interval‐Censored Data · SiM · 2024-11-14 · 在第 4 页
- A Bayesian Approach to Modeling Variance of Intensive Longitudinal Biomarker Data as a Predictor of Health Outcomes · SiM · 2024-11-14 · 在第 4 页
- ℓ1$$ {\ell}_1 $$‐Penalized Multinomial Regression: Estimation, Inference, and Prediction, With an Application to Risk Factor Identification for Different Dementia Subtypes · SiM · 2024-11-12 · 在第 4 页
- Transformed ROC Curve for Biomarker Evaluation · SiM · 2024-11-12 · 在第 4 页
- Shape Mediation Analysis in Alzheimer's Disease Studies · SiM · 2024-11-12 · 在第 4 页
- A Hierarchical Bayesian Model for Estimating Age‐Specific COVID‐19 Infection Fatality Rates in Developing Countries · SiM · 2024-11-11 · 在第 4 页
- A General Framework for the Multiple Nonparametric Behrens–Fisher Problem With Dependent Replicates · SiM · 2024-11-11 · 在第 4 页
- Generalized Fused Lasso for Treatment Pooling in Network Meta‐Analysis · SiM · 2024-11-07 · 在第 5 页
- Permutation Test for Image‐on‐Scalar Regression With an Application to Breast Cancer · SiM · 2024-11-05 · 在第 5 页
- Drug Efficacy Estimation for Follow‐on Companion Diagnostic Devices Through External Studies · SiM · 2024-11-05 · 在第 5 页
- Bayesian Safety and Futility Monitoring in Phase II Trials Using One Utility‐Based Rule · SiM · 2024-11-05 · 在第 5 页
- Empirical Sandwich Variance Estimator for Iterated Conditional Expectation g‐Computation · SiM · 2024-11-03 · 在第 5 页
- Advancing Interpretable Regression Analysis for Binary Data: A Novel Distributed Algorithm Approach · SiM · 2024-11-03 · 在第 5 页
- Dose Individualization for Phase I Cancer Trials With Broadened Eligibility · SiM · 2024-10-31 · 在第 5 页
- A Comparison of Variance Estimators for Logistic Regression Models Estimated Using Generalized Estimating Equations (GEE) in the Context of Observational Health Services Research · SiM · 2024-10-31 · 在第 5 页
- Estimands and Cumulative Incidence Function Regression in Clinical Trials: Some New Results on Interpretability and Robustness · SiM · 2024-10-29 · 在第 5 页
- Heterogeneous Mediation Analysis for Cox Proportional Hazards Model With Multiple Mediators · SiM · 2024-10-28 · 在第 5 页
- A Brief Introduction on Latent Variable Based Ordinal Regression Models With an Application to Survey Data · SiM · 2024-10-28 · 在第 5 页
- New Quadratic Discriminant Analysis Algorithms for Correlated Audiometric Data · SiM · 2024-10-25 · 在第 5 页
- A Modified Debiased Inverse‐Variance Weighted Estimator in Two‐Sample Summary‐Data Mendelian Randomization · SiM · 2024-10-25 · 在第 5 页
- Multivariate Cluster Point Process to Quantify and Explore Multi‐Entity Configurations: Application to Biofilm Image Data · SiM · 2024-10-24 · 在第 5 页
- Bayesian Empirical Likelihood Regression for Semiparametric Estimation of Optimal Dynamic Treatment Regimes · SiM · 2024-10-24 · 在第 5 页
- Genetic Prediction Modeling in Large Cohort Studies via Boosting Targeted Loss Functions · SiM · 2024-10-23 · 在第 5 页
- Functional Principal Component Analysis for Continuous Non‐Gaussian, Truncated, and Discrete Functional Data · SiM · 2024-10-23 · 在第 5 页
- Phase I/II Design for Selecting Subgroup‐Specific Optimal Biological Doses for Prespecified Subgroups · SiM · 2024-10-18 · 在第 6 页
- Causal Inference for Continuous Multiple Time Point Interventions · SiM · 2024-10-17 · 在第 6 页
- A Nonparametric Global Win Probability Approach to the Analysis and Sizing of Randomized Controlled Trials With Multiple Endpoints of Different Scales and Missing Data: Beyond O'Brien–Wei–Lachin · SiM · 2024-10-17 · 在第 6 页
- Variability in Causal Effects and Noncompliance in a Multisite Trial: A Bivariate Hierarchical Generalized Random Coefficients Model for a Binary Outcome · SiM · 2024-10-15 · 在第 6 页
- Evaluating individualized treatment effect predictions: A model‐based perspective on discrimination and calibration assessment · SiM · 2024-10-15 · 在第 6 页
- Clustering Functional Data With Measurement Errors: A Simulation‐Based Approach · SiM · 2024-10-15 · 在第 6 页
- Testing Similarity of Parametric Competing Risks Models for Identifying Potentially Similar Pathways in Healthcare · SiM · 2024-10-12 · 在第 6 页
- Deep Neural Network‐Based Accelerated Failure Time Models Using Rank Loss · SiM · 2024-10-12 · 在第 6 页
- Does Remdesivir Lower COVID‐19 Mortality? A Subgroup Analysis of Hospitalized Adults Receiving Supplemental Oxygen · SiM · 2024-10-10 · 在第 6 页
- A Novel Bayesian Spatio‐Temporal Surveillance Metric to Predict Emerging Infectious Disease Areas of High Disease Risk · SiM · 2024-10-10 · 在第 6 页
- Modeling Chronic Disease Mortality by Methods From Accelerated Life Testing · SiM · 2024-10-09 · 在第 6 页
- A Complex Meta‐Regression Model to Identify Effective Features of Interventions From Multi‐Arm, Multi‐Follow‐Up Trials · SiM · 2024-10-09 · 在第 6 页
- Leveraging External Aggregated Information for the Marginal Accelerated Failure Time Model · SiM · 2024-10-08 · 在第 6 页
- Combining Biomarkers to Improve Diagnostic Accuracy in Detecting Diseases With Group‐Tested Data · SiM · 2024-10-07 · 在第 7 页
- Causal Inference Over a Subpopulation: The Effect of Malaria Vaccine in Women During Pregnancy · SiM · 2024-10-07 · 在第 7 页
- Estimating Time‐Varying Exposure Effects Through Continuous‐Time Modelling in Mendelian Randomization · SiM · 2024-10-06 · 在第 7 页
- Regression Approaches to Assess Effect of Treatments That Arrest Progression of Symptoms · SiM · 2024-10-04 · 在第 7 页
- Pairwise Accelerated Failure Time Regression Models for Infectious Disease Transmission in Close‐Contact Groups With External Sources of Infection · SiM · 2024-10-03 · 在第 7 页
- Latent Archetypes of the Spatial Patterns of Cancer · SiM · 2024-10-03 · 在第 7 页
- Weighted Expectile Regression Neural Networks for Right Censored Data · SiM · 2024-09-29 · 在第 7 页
- A Precision Mixture Risk Model to Identify Adverse Drug Events in Subpopulations Using a Case‐Crossover Design · SiM · 2024-09-19 · 在第 8 页
- Transportability of model‐based estimands in evidence synthesis · SiM · 2024-09-18 · 在第 8 页
- Nonparametric Biomarker Based Treatment Selection With Reproducibility Data · SiM · 2024-09-18 · 在第 8 页
- Group Response‐Adaptive Randomization With Delayed and Missing Responses · SiM · 2024-09-16 · 在第 8 页
- Asymptotic Confidence Interval, Sample Size Formulas and Comparison Test for the Agreement Intra‐Class Correlation Coefficient in Inter‐Rater Reliability Studies · SiM · 2024-09-16 · 在第 8 页
- Trivariate Joint Modeling for Family Data with Longitudinal Counts, Recurrent Events and a Terminal Event with Application to Lynch Syndrome · SiM · 2024-09-15 · 在第 8 页
- Addressing the implementation challenge of risk prediction model due to missing risk factors: The submodel approximation approach · SiM · 2024-09-12 · 在第 8 页
- The spike‐and‐slab quantile LASSO for robust variable selection in cancer genomics studies · SiM · 2024-09-11 · 在第 8 页
- Latent classification model for censored longitudinal binary outcome · SiM · 2024-09-10 · 在第 8 页
- Exploratory subgroup identification in the heterogeneous Cox model: A relatively simple procedure · SiM · 2024-09-10 · 在第 8 页
- Selection of number of clusters and warping penalty in clustering functional electrocardiogram · SiM · 2024-09-09 · 在第 9 页
- Mediation Analysis with Multiple Exposures and Multiple Mediators · SiM · 2024-09-09 · 在第 9 页
- Functional Principal Component Analysis as an Alternative to Mixed‐Effect Models for Describing Sparse Repeated Measures in Presence of Missing Data · SiM · 2024-09-09 · 在第 9 页
- High‐Dimensional Overdispersed Generalized Factor Model With Application to Single‐Cell Sequencing Data Analysis · SiM · 2024-09-05 · 在第 9 页
- Assessing the Performance of Machine Learning Methods Trained on Public Health Observational Data: A Case Study From COVID‐19 · SiM · 2024-09-05 · 在第 9 页
- Approximate maximum likelihood estimation in cure models using aggregated data, with application to HPV vaccine completion · SiM · 2024-09-05 · 在第 9 页
- A Causal Mediation Approach to Account for Interaction of Treatment and Intercurrent Events: Using Hypothetical Strategy · SiM · 2024-09-05 · 在第 9 页
- Performance of mixed effects models and generalized estimating equations for continuous outcomes in partially clustered trials including both independent and paired data · SiM · 2024-09-04 · 在第 9 页
- Multilevel Longitudinal Functional Principal Component Model · SiM · 2024-09-03 · 在第 9 页
- Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs · SiM · 2024-09-03 · 在第 9 页
- Anomaly Detection and Correction in Dense Functional Data Within Electronic Medical Records · SiM · 2024-09-03 · 在第 9 页
- A simulation study of the performance of statistical models for count outcomes with excessive zeros · SiM · 2024-08-28 · 在第 9 页
- A hybrid approach to sample size re‐estimation in cluster randomized trials with continuous outcomes · SiM · 2024-08-28 · 在第 9 页
- Modeling multiple‐criterion diagnoses by heterogeneous‐instance logistic regression · SiM · 2024-08-27 · 在第 9 页
- Estimating causes of maternal death in data‐sparse contexts · SiM · 2024-08-27 · 在第 9 页
- Group sequential designs for clinical trials when the maximum sample size is uncertain · SiM · 2024-08-21 · 在第 9 页
- Calibrating machine learning approaches for probability estimation: A short expansion · SiM · 2024-08-21 · 在第 10 页
- Optimal subsampling for semi‐parametric accelerated failure time models with massive survival data using a rank‐based approach · SiM · 2024-08-20 · 在第 10 页
- Principal quantile treatment effect estimation using principal scores · SiM · 2024-08-19 · 在第 10 页
- Comparing methods for assessing the reliability of health care quality measures · SiM · 2024-08-15 · 在第 10 页
- A novel block‐coordinate gradient descent algorithm for simultaneous grouped selection of fixed and random effects in joint modeling · SiM · 2024-08-15 · 在第 10 页
- Scalar‐on‐function regression: Estimation and inference under complex survey designs · SiM · 2024-08-13 · 在第 10 页
- A modeling framework for the analysis of the SARS‐CoV2 transmission dynamics · SiM · 2024-08-09 · 在第 10 页
- Path‐specific causal decomposition analysis with multiple correlated mediator variables · SiM · 2024-08-07 · 在第 10 页
- Exact test and exact confidence interval for the Cox model · SiM · 2024-08-07 · 在第 10 页
- Dynamic path analysis for exploring treatment effect mediation processes in clinical trials with time‐to‐event endpoints · SiM · 2024-08-07 · 在第 10 页
- The effect of number of clusters and magnitude of within‐cluster homogeneity in outcomes on the performance of four variance estimators for a marginal multivariable Cox regression model fit to clustered data in the context of observational research · SiM · 2024-07-30 · 在第 11 页
- Modeling intra‐individual inter‐trial EEG response variability in autism · SiM · 2024-07-30 · 在第 11 页
- How estimating nuisance parameters can reduce the variance (with consistent variance estimation) · SiM · 2024-07-30 · 在第 11 页
- Evaluation and comparison of covariate balance metrics in studies with time‐dependent confounding · SiM · 2024-07-30 · 在第 11 页
- Validation of predicted individual treatment effects in out of sample respondents · SiM · 2024-07-29 · 在第 11 页
- Identification and estimation of causal effects in the presence of confounded principal strata · SiM · 2024-07-29 · 在第 11 页
- Dual‐agent dose‐finding in Phase I clinical trial—An extension of rapid enrollment design · SiM · 2024-07-29 · 在第 11 页
- Separable and controlled direct effects for competing events: Estimation of component specific effects on sickness absence · SiM · 2024-07-25 · 在第 11 页
- Optimal model averaging for partially linear models with missing response variables and error‐prone covariates · SiM · 2024-07-25 · 在第 11 页
- Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data · SiM · 2024-07-25 · 在第 11 页
- Using a monotonic density ratio model to increase the power of the goodness‐of‐fit test for logistic regression models with case‐control data · SiM · 2024-07-23 · 在第 11 页
- Shortest path or random walks? A framework for path weights in network meta‐analysis · SiM · 2024-07-23 · 在第 11 页
- Using instruments for selection to adjust for selection bias in Mendelian randomization · SiM · 2024-07-22 · 在第 11 页
- An augmented illness‐death model for semi‐competing risks with clinically immediate terminal events · SiM · 2024-07-22 · 在第 11 页
- Bayesian modeling of spatial ordinal data from health surveys · SiM · 2024-07-18 · 在第 12 页
- A latent variable approach to jointly modeling longitudinal and cumulative event data using a weighted two‐stage method · SiM · 2024-07-18 · 在第 12 页
- Extending the DeLong algorithm for comparing areas under correlated receiver operating characteristic curves with missing data · SiM · 2024-07-16 · 在第 12 页
- Dynamic undirected graphical models for time‐varying clinical symptom and neuroimaging networks · SiM · 2024-07-15 · 在第 12 页
- Prefiltered component‐based greedy (PreCoG) scan method · SiM · 2024-07-11 · 在第 12 页
- Exploiting relationship directionality to enhance statistical modeling of peer‐influence across social networks · SiM · 2024-07-09 · 在第 12 页
- Determining sample size in a personalized randomized controlled ( PRACTical ) trial · SiM · 2024-07-09 · 在第 12 页
- A sequential, multiple assignment, randomized trial design with a tailoring function · SiM · 2024-07-08 · 在第 12 页
- A Bayesian semi‐parametric scalar‐on‐function regression with measurement error using instrumental variables · SiM · 2024-07-08 · 在第 12 页
- Covariate‐adjusted generalized pairwise comparisons in small samples · SiM · 2024-07-04 · 在第 12 页
- BHAFT: Bayesian heredity‐constrained accelerated failure time models for detecting gene‐environment interactions in survival analysis · SiM · 2024-07-04 · 在第 12 页
- A Bayesian non‐stationary heteroskedastic time series model for multivariate critical care data · SiM · 2024-07-02 · 在第 12 页
- Time‐varying dynamic Bayesian network learning for an fMRI study of emotion processing · SiM · 2024-06-30 · 在第 13 页
- Online causal inference with application to near real‐time post‐market vaccine safety surveillance · SiM · 2024-06-30 · 在第 13 页
- Addressing dispersion in mis‐measured multivariate binomial outcomes: A novel statistical approach for detecting differentially methylated regions in bisulfite sequencing data · SiM · 2024-06-26 · 在第 13 页
- Propensity score weighted multi‐source exchangeability models for incorporating external control data in randomized clinical trials · SiM · 2024-06-24 · 在第 13 页
- Differential network knockoff filter with application to brain connectivity analysis · SiM · 2024-06-24 · 在第 13 页
- A multivariate to multivariate approach for voxel‐wise genome‐wide association analysis · SiM · 2024-06-24 · 在第 13 页
- Integrative deep learning with prior assisted feature selection · SiM · 2024-06-23 · 在第 13 页
- Bayesian survival analysis with INLA · SiM · 2024-06-23 · 在第 13 页
- Robust inference methods for meta‐analysis involving influential outlying studies · SiM · 2024-06-20 · 在第 13 页
- Renewable risk assessment of heterogeneous streaming time‐to‐event cohorts · SiM · 2024-06-19 · 在第 13 页
- Nonparametric empirical Bayes biomarker imputation and estimation · SiM · 2024-06-19 · 在第 13 页
- deepAFT: A nonlinear accelerated failure time model with artificial neural network · SiM · 2024-06-18 · 在第 13 页
- Sensitivity analysis for principal ignorability violation in estimating complier and noncomplier average causal effects · SiM · 2024-06-18 · 在第 13 页
- Data fusion for predicting long‐term program impacts · SiM · 2024-06-18 · 在第 13 页
- Bayesian mixture modelling with ranked set samples · SiM · 2024-06-18 · 在第 13 页
- Improved mortality analysis in early‐phase dose‐ranging clinical trials for emergency medical diseases using Bayesian time‐to‐event models with active comparators · SiM · 2024-06-17 · 在第 13 页
- A sparse factor model for clustering high‐dimensional longitudinal data · SiM · 2024-06-17 · 在第 13 页
- Generalized single index modeling of longitudinal data with multiple binary responses · SiM · 2024-06-16 · 在第 13 页
- Comparing two hazard curves when there is a treatment time‐lag effect · SiM · 2024-06-16 · 在第 13 页
- Assurance methods for designing a clinical trial with a delayed treatment effect · SiM · 2024-06-16 · 在第 13 页
- A multi‐arm multi‐stage platform design that allows preplanned addition of arms while still controlling the family‐wise error · SiM · 2024-06-16 · 在第 13 页
- Dynamic hierarchical state space forecasting · SiM · 2024-06-15 · 在第 14 页
- Cumulative incidence of cardiac surgery associated with exposure to benfluorex: A retrospective analysis based on compensation claims data · SiM · 2024-06-15 · 在第 14 页
- Non‐parametric inference on calibration of predicted risks · SiM · 2024-06-11 · 在第 14 页
- REDOMA: Bayesian random‐effects dose‐optimization meta‐analysis using spike‐and‐slab priors · SiM · 2024-06-10 · 在第 14 页
- Conditional score approaches to errors‐in‐variables competing risks data in discrete time · SiM · 2024-06-10 · 在第 14 页
- Categorical linkage‐data analysis · SiM · 2024-06-10 · 在第 14 页
- Familywise error for multiple time‐to‐event endpoints in a group sequential design · SiM · 2024-06-09 · 在第 14 页
- Bayesian transition models for ordinal longitudinal outcomes · SiM · 2024-06-09 · 在第 14 页
- Bayesian hierarchical profile regression for binary covariates · SiM · 2024-06-09 · 在第 14 页
- Adding experimental treatment arms to multi‐arm multi‐stage platform trials in progress · SiM · 2024-06-09 · 在第 14 页
- Model‐based bioequivalence approach for sparse pharmacokinetic bioequivalence studies: Model selection or model averaging? · SiM · 2024-06-07 · 在第 14 页
- Two‐stage randomized clinical trials with a right‐censored endpoint: Comparison of frequentist and Bayesian adaptive designs · SiM · 2024-06-06 · 在第 14 页
- A seamless phase II/III design with dose optimization for oncology drug development · SiM · 2024-06-06 · 在第 14 页
- A Bayesian method to detect drug‐drug interaction using external information for spontaneous reporting system · SiM · 2024-06-05 · 在第 14 页
- Robust analysis of stepped wedge trials using composite likelihood models · SiM · 2024-06-04 · 在第 14 页
- Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi‐center clinical trial · SiM · 2024-06-03 · 在第 15 页
- Detecting responsible nodes in differential Bayesian networks · SiM · 2024-06-03 · 在第 15 页
- Bridging the gap between two‐stage and joint models: The case of tumor growth inhibition and overall survival models · SiM · 2024-06-03 · 在第 15 页
- Statistical methods for predicting e‐cigarette use events based on beat‐to‐beat interval (BBI) data collected from wearable devices · SiM · 2024-05-30 · 在第 15 页
- Fractional accumulative calibration‐free odds (f‐aCFO) design for delayed toxicity in phase I clinical trials · SiM · 2024-05-30 · 在第 15 页
- Assessing efficacy in non‐inferiority trials with non‐adherence to interventions: Are intention‐to‐treat and per‐protocol analyses fit for purpose? · SiM · 2024-05-30 · 在第 15 页
- Approximate balancing weights for clustered observational study designs · SiM · 2024-05-30 · 在第 15 页
- Assessing heterogeneity in surrogacy using censored data · SiM · 2024-05-29 · 在第 15 页
- Structured learning in time‐dependent Cox models · SiM · 2024-05-28 · 在第 15 页
- Sample size determination for prediction models via learning‐type curves · SiM · 2024-05-27 · 在第 16 页
- Flexible cost‐penalized Bayesian model selection: Developing inclusion paths with an application to diagnosis of heart disease · SiM · 2024-05-27 · 在第 16 页
- Efficient matrix profile computation with Euclidean distance using Eigen transformation: Performance evaluation based on beat‐to‐beat interval (BBI) data · SiM · 2024-05-27 · 在第 16 页
- Balancing versus modelling in weighted analysis of non‐randomised studies with survival outcomes: A simulation study · SiM · 2024-05-27 · 在第 16 页
- An enhanced cross‐sectional HIV incidence estimator that incorporates prior HIV test results · SiM · 2024-05-27 · 在第 16 页
- Prognostic score‐based methods for estimating center effects based on survival probability: Application to post‐kidney transplant survival · SiM · 2024-05-23 · 在第 16 页
- Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two‐by‐two table · SiM · 2024-05-23 · 在第 16 页
- Robust inference for causal mediation analysis of recurrent event data · SiM · 2024-05-21 · 在第 16 页
- Standardization and other approaches to meta‐analyze differences in means · SiM · 2024-05-18 · 在第 16 页
- HIV estimation using population‐based surveys with non‐response: A partial identification approach · SiM · 2024-05-17 · 在第 16 页
- Sample size calculation for comparing two screening tests when the gold standard is missing at random · SiM · 2024-05-15 · 在第 16 页
- Random effects models of tumour growth for investigating interval breast cancer · SiM · 2024-05-15 · 在第 16 页
- Design and sample size determination for multiple‐dose randomized phase II trials for dose optimization · SiM · 2024-05-15 · 在第 17 页
- A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials · SiM · 2024-05-14 · 在第 17 页
- A fast bootstrap algorithm for causal inference with large data · SiM · 2024-05-13 · 在第 17 页
- Causal mediation analysis with a three‐dimensional image mediator · SiM · 2024-05-11 · 在第 17 页
- Novel non‐linear models for clinical trial analysis with longitudinal data: A tutorial using SAS for both frequentist and Bayesian methods · SiM · 2024-05-10 · 在第 17 页
- G‐formula for observational studies under stratified interference, with application to bed net use on malaria · SiM · 2024-05-10 · 在第 17 页
- Calibration plots for multistate risk prediction models · SiM · 2024-05-08 · 在第 17 页
- Adaptive designs in public health: Vaccine and cluster randomized trials go Bayesian · SiM · 2024-05-08 · 在第 17 页
- Propensity score matching for estimating a marginal hazard ratio · SiM · 2024-05-05 · 在第 17 页
- Learning optimal biomarker‐guided treatment policy for chronic disorders · SiM · 2024-05-03 · 在第 17 页
- Negative variance components and intercept‐slope correlations greater than one in magnitude: How do such “non‐regular” random intercept and slope models arise, and what should be done when they do? · SiM · 2024-05-02 · 在第 17 页
- Distributional imputation for the analysis of censored recurrent events · SiM · 2024-04-29 · 在第 17 页
- Flexible parametrization of graph‐theoretical features from individual‐specific networks for prediction · SiM · 2024-04-25 · 在第 17 页
- Enhancing long‐term survival prediction with two short‐term events: Landmarking with a flexible varying coefficient model · SiM · 2024-04-25 · 在第 17 页
- Weighting estimation in the cause‐specific Cox regression with partially missing causes of failure · SiM · 2024-04-24 · 在第 17 页
- Variance‐components tests for genetic association with multiple interval‐censored outcomes · SiM · 2024-04-18 · 在第 18 页
- Population‐average mediation analysis for zero‐inflated count outcomes · SiM · 2024-04-18 · 在第 18 页
- Order selection for heterogeneous semiparametric hidden Markov models · SiM · 2024-04-15 · 在第 18 页
- On variance estimation of the inverse probability‐of‐treatment weighting estimator: A tutorial for different types of propensity score weights · SiM · 2024-04-15 · 在第 18 页
- Multiblock partial least squares and rank aggregation: Applications to detection of bacteriophages associated with antimicrobial resistance in the presence of potential confounding factors · SiM · 2024-04-15 · 在第 18 页
- Finding the best subgroup with differential treatment effect with multiple outcomes · SiM · 2024-04-15 · 在第 18 页
- Mediation analysis using incomplete information from publicly available data sources · SiM · 2024-04-12 · 在第 18 页
- Statistical considerations in model‐based dose finding for binary responses under model uncertainty · SiM · 2024-04-11 · 在第 18 页
- A discrete approximation method for modeling interval‐censored multistate data · SiM · 2024-04-10 · 在第 18 页
- A Bayesian platform trial design with hybrid control based on multisource exchangeability modelling · SiM · 2024-04-09 · 在第 18 页
- Individualized empirical null estimation for exact tests of healthcare quality · SiM · 2024-04-08 · 在第 18 页
- Bayesian federated inference for estimating statistical models based on non‐shared multicenter data sets · SiM · 2024-04-08 · 在第 18 页
- Beyond the two‐trials rule · SiM · 2024-04-04 · 在第 18 页
- Confidence intervals for odds ratio from multistage randomized phase II trials · SiM · 2024-04-02 · 在第 19 页
- A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart · SiM · 2024-04-02 · 在第 19 页
- A joint frailty model for recurrent and competing terminal events: Application to delirium in the ICU · SiM · 2024-04-02 · 在第 19 页
- Causal mediation analysis with mediator values below an assay limit · SiM · 2024-03-31 · 在第 19 页
- Information‐incorporated sparse hierarchical cancer heterogeneity analysis · SiM · 2024-03-30 · 在第 19 页
- Collaborative inference for treatment effect with distributed data‐sharing management in multicenter studies · SiM · 2024-03-29 · 在第 19 页
- Sample size adaptation designs and efficiency comparison with group sequential designs · SiM · 2024-03-28 · 在第 19 页
- How could a pooled testing policy have performed in managing the early stages of the COVID‐19 pandemic? Results from a simulation study · SiM · 2024-03-28 · 在第 19 页
- A nonparametric relative treatment effect for direct comparisons of censored paired survival outcomes · SiM · 2024-03-28 · 在第 19 页
- Model‐agnostic explanations for survival prediction models · SiM · 2024-03-26 · 在第 20 页
- Estimating generalized propensity scores with survey and attrition weighted data · SiM · 2024-03-26 · 在第 20 页
- Predicting the multivariate zero‐inflated counts: A novel model averaging method under Pearson loss · SiM · 2024-03-15 · 在第 20 页
- Monitoring epidemic processes under political measures · SiM · 2024-03-15 · 在第 20 页
- Categorisation of continuous covariates for stratified randomisation: How should we adjust? · SiM · 2024-03-15 · 在第 20 页
- An information‐theoretic approach for the assessment of a continuous outcome as a surrogate for a binary true endpoint based on causal inference: Application to vaccine evaluation · SiM · 2024-03-15 · 在第 20 页
- Do machine learning methods lead to similar individualized treatment rules? A comparison study on real data · SiM · 2024-03-12 · 在第 20 页
- A new and unified method for regression analysis of interval‐censored failure time data under semiparametric transformation models with missing covariates · SiM · 2024-03-12 · 在第 20 页
- Penalized weighted smoothed quantile regression for high‐dimensional longitudinal data · SiM · 2024-03-08 · 在第 21 页
- On the distribution of the power function for the scale parameter of exponential families · SiM · 2024-03-05 · 在第 21 页
- A class of computational methods to reduce selection bias when designing Phase 3 clinical trials · SiM · 2024-03-05 · 在第 21 页
- Estimation and reduction of bias in self‐controlled case series with non‐rare event dependent outcomes and heterogeneous populations · SiM · 2024-03-04 · 在第 21 页
- Inference under superspreading: Determinants of SARS‐CoV‐2 transmission in Germany · SiM · 2024-02-29 · 在第 21 页
- Use of win time for ordered composite endpoints in clinical trials · SiM · 2024-02-28 · 在第 21 页
- Two‐stage stratified designs with survival outcomes and adjustment for misclassification in predictive biomarkers · SiM · 2024-02-26 · 在第 22 页
- Detecting changes in the transmission rate of a stochastic epidemic model · SiM · 2024-02-26 · 在第 22 页
- A Bayesian nonparametric meta‐analysis model for estimating the reference interval · SiM · 2024-02-26 · 在第 22 页
- Robust best linear weighted estimator with missing covariates in survival analysis · SiM · 2024-02-25 · 在第 22 页
- RMST‐based multiple contrast tests in general factorial designs · SiM · 2024-02-25 · 在第 22 页
- Optimal ensemble construction for multistudy prediction with applications to mortality estimation · SiM · 2024-02-23 · 在第 22 页
- Estimation of trajectory of protective efficacy in infectious disease prevention trials using recurrent event times · SiM · 2024-02-23 · 在第 22 页
- Doubly adaptive biased coin design to improve Bayesian clinical trials with time‐to‐event endpoints · SiM · 2024-02-22 · 在第 22 页
- Martingale‐residual‐based greedy model averaging for high‐dimensional current status data · SiM · 2024-02-21 · 在第 22 页
- Handling missing disease information due to death in diseases that need two visits to diagnose · SiM · 2024-02-21 · 在第 22 页
- Statistical inference with large‐scale trait imputation · SiM · 2024-02-20 · 在第 22 页
- Parameter estimation and forecasting with quantified uncertainty for ordinary differential equation models using QuantDiffForecast: A MATLAB toolbox and tutorial · SiM · 2024-02-20 · 在第 22 页
- Are the tests overpowered or underpowered? A unified solution to correctly specify type I errors in design of clinical trials for two sample proportions · SiM · 2024-02-19 · 在第 22 页
- Statistical plasmode simulations–Potentials, challenges and recommendations · SiM · 2024-02-14 · 在第 23 页
- Shape restricted additive hazards models: Monotone, unimodal, and U‐shape hazard functions · SiM · 2024-02-14 · 在第 23 页
- Utilizing local likelihood in regression discontinuity design: Investigating the impact of antiretroviral therapy eligibility on retention in clinical HIV care in South Africa · SiM · 2024-02-13 · 在第 23 页
- Modeling correlated pairs of mammogram images · SiM · 2024-02-13 · 在第 23 页
- Methods for the estimation of direct and indirect vaccination effects by combining data from individual‐ and cluster‐randomized trials · SiM · 2024-02-13 · 在第 23 页
- A scaled kernel density estimation prior for dynamic borrowing of historical information with application to clinical trial design · SiM · 2024-02-12 · 在第 23 页
- Distribution–free hyperrectangular tolerance regions for setting multivariate reference regions in laboratory medicine · SiM · 2024-02-11 · 在第 23 页
- Point estimation, confidence intervals, and P‐values for optimal adaptive two‐stage designs with normal endpoints · SiM · 2024-02-10 · 在第 23 页
- Cutoff estimation and construction of their confidence intervals for continuous biomarkers under ternary umbrella and tree stochastic ordering settings · SiM · 2024-02-10 · 在第 23 页
- Bayesian hierarchical modeling in interim futility analysis for two parallel clinical trials · SiM · 2024-02-10 · 在第 23 页
- A flexible multi‐metric Bayesian framework for decision‐making in Phase II multi‐arm multi‐stage studies · SiM · 2024-02-10 · 在第 24 页
- Generalized functional linear model with a point process predictor · SiM · 2024-02-08 · 在第 24 页
- Simultaneous variable selection and estimation for survival data via the Gaussian seamless‐L0$$ {L}_0 $$ penalty · SiM · 2024-02-06 · 在第 24 页
- Sensitivity analysis with iterative outlier detection for systematic reviews and meta‐analyses · SiM · 2024-02-06 · 在第 24 页
- Multivariate probit linear mixed models for multivariate longitudinal binary data · SiM · 2024-02-06 · 在第 24 页
- Targeted learning in observational studies with multi‐valued treatments: An evaluation of antipsychotic drug treatment safety · SiM · 2024-02-05 · 在第 24 页
- Scaled average bioequivalence methods for highly variable drugs: Leveling‐off soft limits and the EMA's 2010 guideline (some ways to improve its type I error control) · SiM · 2024-02-05 · 在第 24 页
- Multiply robust generalized estimating equations for cluster randomized trials with missing outcomes · SiM · 2024-02-05 · 在第 24 页
- Statistical inference on qualitative differences in the magnitude of an effect · SiM · 2024-02-02 · 在第 24 页
- Modeling variation in mixture effects over space with a Bayesian spatially varying mixture model · SiM · 2024-02-02 · 在第 24 页
- Safety signal detection with control of latent factors · SiM · 2024-01-31 · 在第 25 页
- Effective sample size: A measure of individual uncertainty in predictions · SiM · 2024-01-31 · 在第 25 页
- Likelihood ratio combination of multiple biomarkers via smoothing spline estimated densities · SiM · 2024-01-30 · 在第 25 页
- Nonparametric estimation of linear personalized diagnostics rules via efficient grid algorithm · SiM · 2024-01-29 · 在第 25 页
- Addressing subject heterogeneity in time‐dependent discrimination for biomarker evaluation · SiM · 2024-01-29 · 在第 25 页
- Classified functional mixed effects model prediction · SiM · 2024-01-27 · 在第 25 页
- Optimizing dynamic predictions from joint models using super learning · SiM · 2024-01-25 · 在第 25 页
- Comparison of methods that combine multiple randomized trials to estimate heterogeneous treatment effects · SiM · 2024-01-25 · 在第 25 页
- Bayesian response adaptive randomization design with a composite endpoint of mortality and morbidity · SiM · 2024-01-23 · 在第 25 页
- Multiple imputation strategies for missing event times in a multi‐state model analysis · SiM · 2024-01-22 · 在第 25 页
- Statistical performance review on diagnosis of leukemia, glaucoma and diabetes mellitus using AI · SiM · 2024-01-21 · 在第 25 页
- Efficient estimation of Cox model with random change point · SiM · 2024-01-21 · 在第 25 页
- τ$$ \tau $$‐Inflated beta regression model for censored recurrent events · SiM · 2024-01-20 · 在第 25 页
- Steady‐state statistical properties and implementation of randomization designs with maximum tolerated imbalance restriction for two‐arm equal allocation clinical trials · SiM · 2024-01-20 · 在第 25 页
- A Bayesian framework for modeling COVID‐19 case numbers through longitudinal monitoring of SARS‐CoV‐2 RNA in wastewater · SiM · 2024-01-14 · 在第 25 页
- Confidence distributions for treatment effects in clinical trials: Posteriors without priors · SiM · 2024-01-11 · 在第 26 页
- Joint modeling of association networks and longitudinal biomarkers: An application to childhood obesity · SiM · 2024-01-10 · 在第 26 页
- A comparison of hyperparameter tuning procedures for clinical prediction models: A simulation study · SiM · 2024-01-08 · 在第 26 页
- Confidence sets for a level set in linear regression · SiM · 2024-01-06 · 在第 26 页